AAAAAA
Results:
1-22
|
Results: 22
Authors:
Calvet, X
Nogueras, C
Roque, M
Sanfeliu, I
Citation: X. Calvet et al., Helicobacter pylori is not a risk factor for hepatic encephalopathy, DIG LIVER D, 33(5), 2001, pp. 414-419
Authors:
Gisbert, JP
Gonzalez, L
Calvet, X
Roque, M
Gabriel, R
Pajares, JM
Citation: Jp. Gisbert et al., Proton pump inhibitors versus H-2-antagonists: a meta-anaiysis of their efficacy in treating bleeding peptic ulcer, ALIM PHARM, 15(7), 2001, pp. 917-926
Authors:
Calvet, X
Garcia, N
Gene, E
Campo, R
Brullet, E
Sanfeliu, I
Citation: X. Calvet et al., Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment, ALIM PHARM, 15(7), 2001, pp. 1061-1065
Authors:
Calvet, X
Gene, E
Lopez, T
Gisbert, JP
Citation: X. Calvet et al., What is the optimal length of proton pump inhibitor-based triple therapiesfor H-pylori? A cost-effectiveness analysis, ALIM PHARM, 15(7), 2001, pp. 1067-1076
Authors:
Sillero, JM
Calvet, X
Musulen, E
Diaz-Ruiz, MJ
Tolosa, C
Pardo, A
Corcuera, A
Malet, A
Font, J
Citation: Jm. Sillero et al., Idiopathic pylephlebitis and idiopathic sclerosing peritonitis in a man with protein S deficiency, J CLIN GAST, 32(3), 2001, pp. 262-265
Authors:
Calvet, X
Gene, E
Sanfeliu, I
Citation: X. Calvet et al., Therapeutic strategies in Helicobacter pylori infection, MED CLIN, 116(6), 2001, pp. 239-239
Authors:
Calvet, X
Tito, L
Comet, R
Garcia, N
Campo, R
Brullet, E
Citation: X. Calvet et al., Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin,tinidazole and omeprazole to cure Helicobacter pylori infection: A pilot study, HELICOBACT, 5(1), 2000, pp. 52-56
Authors:
Calvet, X
Bustamante, E
Montserrat, A
Roque, M
Campo, R
Gene, E
Brullet, E
Citation: X. Calvet et al., Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test, EUR J GASTR, 12(8), 2000, pp. 949-953
Authors:
Campo, R
Brullet, E
Montserrat, A
Calvet, X
Donoso, L
Bordas, JM
Citation: R. Campo et al., Efficacy of low and standard midazolam doses for gastroscopy. A randomized, double-blind study, EUR J GASTR, 12(2), 2000, pp. 187-190
Authors:
Garcia, N
Calvet, X
Gene, E
Campo, R
Brullet, E
Citation: N. Garcia et al., Limited usefulness of a seven-day twice-a-day quadruple therapy, EUR J GASTR, 12(12), 2000, pp. 1315-1318
Authors:
Gisbert, JP
Gonzalez, L
Calvet, X
Roque, M
Gabriel, R
Pajares, JM
Citation: Jp. Gisbert et al., Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week - a meta-analysis of efficacy, ALIM PHARM, 14(9), 2000, pp. 1141-1150
Authors:
Calvet, X
Rue, M
Citation: X. Calvet et M. Rue, Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users, ALIM PHARM, 14(8), 2000, pp. 1105-1106
Authors:
Calvet, X
Garcia, N
Lopez, T
Gisbert, JP
Gene, E
Roque, M
Citation: X. Calvet et al., A meta-analysis of short versus long therapy with a proton pump inhibitor,clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection, ALIM PHARM, 14(5), 2000, pp. 603-609
Authors:
Gene, E
Calvet, X
Azagra, R
Citation: E. Gene et al., Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers - a cost-effectiveness analysis, ALIM PHARM, 14(4), 2000, pp. 433-442
Authors:
Calvet, X
Larrosa, M
Font, J
Gratacos, J
Citation: X. Calvet et al., On dissonances, Helicobacter pylori and NSAIDs, ALIM PHARM, 14(4), 2000, pp. 497-499
Authors:
Gisbert, JP
Gonzalez, L
Calvet, X
Garcia, N
Lopez, T
Roque, M
Gabriel, R
Pajares, JM
Citation: Jp. Gisbert et al., Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori, ALIM PHARM, 14(10), 2000, pp. 1319-1328
Authors:
Gisbert, JP
Calvet, X
Gomollon, F
Sainz, R
Citation: Jp. Gisbert et al., Helicobacter pylori eradication therapy. The Spanish Consensus Report, MED CLIN, 114(5), 2000, pp. 185-195
Authors:
Calvet, X
Carod, C
Gene, E
Citation: X. Calvet et al., Re: Peppers at treatment for Helicobacter pylori infection, AM J GASTRO, 95(3), 2000, pp. 820-821
Authors:
Campo, R
Brullet, E
Montserrat, A
Calvet, X
Moix, J
Rue, M
Roque, M
Donoso, L
Bordas, JM
Citation: R. Campo et al., Identification of factors that influence tolerance of upper gastrointestinal endoscopy, EUR J GASTR, 11(2), 1999, pp. 201-204
Authors:
Calvet, X
Lopez-Lorente, MT
Cubells, MJ
Bare, M
Galvez, E
Molina, E
Citation: X. Calvet et al., Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial, ALIM PHARM, 13(6), 1999, pp. 781-786
Authors:
Calvet, X
Campo, R
Brullet, E
Rue, M
Citation: X. Calvet et al., Triple therapy for cure of Helicobacter pylori infection, MED CLIN, 111(19), 1998, pp. 759-759
Authors:
Calvet, X
Navarro, M
Gil, M
Lafont, A
Sanfeliu, I
Brullet, E
Campo, R
Dalmau, B
Rivero, E
Mas, P
Citation: X. Calvet et al., Epidemiology of peptic ulcer disease in cirrhotic patients: Role of Helicobacter pylori infection, AM J GASTRO, 93(12), 1998, pp. 2501-2507
Risultati:
1-22
|